HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timur Köse Selected Research

Losartan (Cozaar)

10/2019Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Timur Köse Research Topics

Disease

11Chronic Periodontitis
01/2020 - 11/2005
10Aggressive Periodontitis (Periodontosis)
11/2020 - 04/2006
5Periodontitis
01/2020 - 04/2007
4Periodontal Diseases (Periodontal Disease)
04/2021 - 08/2006
3Infections
01/2020 - 08/2005
2Inflammation (Inflammations)
02/2022 - 11/2020
2Neoplasms (Cancer)
02/2022 - 11/2016
2Hypoxia (Hypoxemia)
11/2020 - 01/2019
2Gingivitis
01/2019 - 01/2018
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
03/2022
1Cardiotoxicity
02/2022
1Hypercholesterolemia
02/2022
1Pneumonia (Pneumonitis)
01/2020
1Diabetes Mellitus
10/2019
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2019
1Hypertension (High Blood Pressure)
10/2019
1Necrosis
01/2019
1Panic Disorder (Panic Attack)
12/2018
1Vascular System Injuries
08/2018
1Abscess
08/2018
1Persistent Infection
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2016
1Lung Neoplasms (Lung Cancer)
11/2016
1Migraine with Aura (Familial Hemiplegic Migraine)
10/2016
1Headache (Headaches)
10/2016
1Vertigo (Positional Vertigo)
10/2016
1Migraine Disorders (Migraine)
10/2016
1Type 2 Episodic Ataxia
10/2016
1Acromegaly
08/2015
1Chronic Obstructive Pulmonary Disease (COPD)
04/2015
1Xerostomia
06/2008
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2008
1Hemorrhage
09/2006

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
02/2022 - 10/2016
3DNA (Deoxyribonucleic Acid)IBA
09/2006 - 04/2006
2Biomarkers (Surrogate Marker)IBA
04/2021 - 01/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 01/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020 - 01/2019
2collagen type I trimeric cross-linked peptideIBA
01/2020 - 06/2011
2Collagen Type I (Type I Collagen)IBA
01/2020 - 06/2011
2OsteocalcinIBA
01/2020 - 06/2011
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 08/2005
2InterleukinsIBA
01/2019 - 01/2018
2Matrix Metalloproteinases (MMPs)IBA
08/2014 - 12/2007
2AngiotensinogenIBA
04/2009 - 03/2009
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2009 - 03/2009
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2008 - 12/2007
2Plasminogen Activators (Plasminogen Activator)IBA
07/2007 - 04/2007
2Tissue Plasminogen Activator (Alteplase)FDA Link
07/2007 - 04/2007
2Plasminogen Activator Inhibitor 1IBA
07/2007 - 04/2007
1Clomiphene (Clomifene)FDA LinkGeneric
03/2022
1TamoxifenFDA LinkGeneric
03/2022
1glutaryl-coenzyme A (glutaryl-CoA)IBA
02/2022
1Cytostatic AgentsIBA
02/2022
1Caspase 3 (Caspase-3)IBA
02/2022
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2022
1FluvastatinFDA Link
02/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2022
1Nitric Oxide Synthase (NO Synthase)IBA
02/2022
1CholesterolIBA
02/2022
1NF-kappa B (NF-kB)IBA
02/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022
1Messenger RNA (mRNA)IBA
02/2022
1Proteins (Proteins, Gene)FDA Link
02/2022
1Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
04/2021
1Carbapenems (Carbapenem Antibiotics)IBA
01/2020
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2020
1Antihypertensive Agents (Antihypertensives)IBA
10/2019
1Losartan (Cozaar)FDA LinkGeneric
10/2019
1BilirubinIBA
08/2018
1CytokinesIBA
01/2018
1Peptide Hydrolases (Proteases)FDA Link
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2018
1ApelinIBA
11/2016
1Acetazolamide (Diamox)FDA LinkGeneric
10/2016
1Folic Acid (Vitamin M)FDA LinkGeneric
08/2015
1Fibrinogen (Factor I)FDA Link
08/2015
1EnzymesIBA
08/2015
1Acetylcysteine (Siran)FDA LinkGeneric
04/2015
1Tissue Inhibitor of Metalloproteinase-1IBA
08/2014
1pyridinolineIBA
06/2011
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
03/2010
1Type 1 Angiotensin ReceptorIBA
04/2009
1Angiotensin IIIBA
03/2009
1AngiotensinsIBA
03/2009
1ReninIBA
03/2009
1xialineIBA
06/2008
1Insulin Glargine (Lantus)FDA Link
03/2008
1Toll-Like Receptor 2IBA
10/2007
1Plasminogen InactivatorsIBA
07/2007
1Tuberculin (PPD)IBA
09/2006
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2006
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
08/2006

Therapy/Procedure

6Therapeutics
11/2020 - 11/2005
2Drug Therapy (Chemotherapy)
02/2022 - 11/2016
2Debridement
01/2020 - 11/2005
1Glycemic Control
03/2008
1Oral Hygiene (Dental Hygiene)
01/2008
1Kidney Transplantation
01/2008